Page last updated: 2024-08-23

mifepristone and cetylpyridinium chloride anhydrous

mifepristone has been researched along with cetylpyridinium chloride anhydrous in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furedi, A1

Other Studies

7 other study(ies) available for mifepristone and cetylpyridinium chloride anhydrous

ArticleYear
[Order of 10 September 1992 on the possession, distribution, dispensing, and administration of the pharmaceutical speciality Mifegyne 200 mg. in tablet form].
    Journal Officiel De La Republique Francaise, Edition Des Lois Et Decrets, 1992, Sep-20

    Topics: Abortion, Induced; Ambulatory Care Facilities; Biology; Delivery of Health Care; Developed Countries; Drug Prescriptions; Economics; Electronic Data Processing; Endocrine System; Europe; Family Planning Services; France; Health; Health Facilities; Health Planning; Hormone Antagonists; Hormones; Legislation as Topic; Marketing of Health Services; Mifepristone; Organization and Administration; Pharmacies; Physiology; Records

1992
USA President Clinton acts to ensure reproductive health.
    IPPF open file, 1993

    Topics: Abortion, Induced; Administrative Personnel; Ambulatory Care Facilities; Americas; Biology; Catholicism; Christianity; Counseling; Developed Countries; Developing Countries; Endocrine System; Extraembryonic Membranes; Family Planning Policy; Family Planning Services; Fetus; Government; Government Agencies; Health; Health Planning; Hormone Antagonists; Hormones; Human Rights; International Agencies; Latin America; Legislation as Topic; Mexico; Mifepristone; North America; Organization and Administration; Organizations; Physiology; Pregnancy; Public Policy; Religion; Reproduction; Reproductive Medicine; Research; United States

1993
Comment.
    Family planning today, 1994

    Topics: Abortifacient Agents; Abortion, Induced; Ambulatory Care Facilities; Biology; Delivery of Health Care; Developed Countries; Endocrine System; England; Europe; Family Planning Services; Health; Health Facilities; Health Services Accessibility; Hormone Antagonists; Hormones; Mifepristone; Physiology; Program Evaluation; United Kingdom

1994
Order on the possession, distribution, dispensing, and administration of the pharmaceutical specialty Mifegyne 200 mg. in tablet form, 28 December 1988.
    Annual review of population law, 1988, Volume: 15

    Topics: Abortion, Induced; Biology; Delivery of Health Care; Developed Countries; Drug Prescriptions; Economics; Electronic Data Processing; Endocrine System; Europe; Family Planning Services; France; Health; Health Personnel; Health Planning; Hormone Antagonists; Hormones; Legislation as Topic; Marketing of Health Services; Mifepristone; Organization and Administration; Pharmacists; Physiology; Records

1988
President Clinton reelected with mandate for choice.
    Reproductive freedom news, 1996, Nov-08, Volume: 5, Issue:18

    Topics: Abortion, Induced; Administrative Personnel; Americas; Biology; Developed Countries; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Government; Health; Hormone Antagonists; Hormones; Human Rights; Legislation as Topic; Mifepristone; North America; Organization and Administration; Physiology; Reproductive Medicine; United States

1996
Abortion.
    State reproductive health monitor : legislative proposals and actions, 1992, Volume: 3, Issue:4

    Topics: Abortion, Induced; Ambulatory Care Facilities; Americas; Biology; Consumer Product Safety; Delivery of Health Care; Developed Countries; Economics; Endocrine System; Extraembryonic Membranes; Family Planning Services; Fetus; Financial Management; Financing, Government; Health; Health Facilities; Hormone Antagonists; Hormones; Human Rights; Individuality; Informed Consent; Insurance, Health; Legislation as Topic; Licensure; Mifepristone; North America; Physiology; Pregnancy; Reproduction; Research; Third-Party Consent; United States

1992
Options expand in wait for mifepristone arrival.
    Contraceptive technology update, 1998, Volume: 19, Issue:12

    Topics: Abortion, Induced; Americas; Biology; Delivery of Health Care; Developed Countries; Endocrine System; Family Planning Services; Health; Health Personnel; Hormone Antagonists; Hormones; Mifepristone; North America; Physicians; Physiology; United States; Vacuum Curettage

1998